With West Texas Intermediate Crude challenging $105 per barrel now, it is time to start assessing the threat of $4.00 per gallon in gasoline. The summer driving season is usually a threat to gas…
Gabelli & Co. has a pretty amazing upside call in Madison Square Garden Company (NYSE: MSG). The firm’s report is after the sports and entertainment operation settled with Time Warner Cable Inc. (NYSE: TWC)…
Manufacturing activity was weak in the key Midwest region based upon the most recent data from the Chicago Fed. The National Activity Index was released this morning by the Chicago Federal Reserve Bank and…
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Tuesday morning: ABB Limited (NYSE: ABB) Cut to Equal Weight at Morgan Stanley. Asbury Automotive…
Web.com Group Inc. (NASDAQ: WWWW) would likely be trading higher this Friday if it had not snuck in a secondary offering after sailing past earnings expectations last night. After closing at $13.35 yesterday, shares…
In recent weeks 24/7 Wall St. noted how January had a very strange coincidence taking place in the alternative investing world of high-end sports memorabilia… The most prized baseball card collectible of them all, the…
United Parcel Service, Inc. (NYSE: UPS) has confirmed some news that the market was expecting. The company is responding to a rejected buyout offer of close to $6 billion which it made to TNT…
Fusion-io, Inc. (NYSE: FIO) is surging today on elevated equity volume and on elevated options trading. We have almost seen twice the normal trading day’s worth of volume in the stock and this is…
Ultra Petroleum Corporation (NYSE: UPL) is seeing some interesting trading in the put options one month out. With today being options expiration date, we’d normally attribute the trading to that. This does not appear…
Brightcove INc. (NASDAQ: BCOV) is surging after its initial public offering this Friday. The cloud video hosting platform operator for enterprises saw its 5 million share IPO price at $11.00 per share, which was…
Superconductor Technologies Inc. (NASDAQ: SCON) is suffering after the company announced this morning that it has entered into agreements with institutional investors to directly place about $4.6 million worth of common stock at a…
A filing for an initial public offering has been made by another ‘cloud’ company called E2open, Inc. This IPO paperwork shows that the company and insiders will be selling shares in the IPO. No financial…
Gilead Sciences, Inc. (NASDAQ: GILD) has recovered from its pre-market lows on the devastating news that its Hepatitis C drug experienced close to a total failure in an arm of a late-stage test group. …
If you want to know about bizarre versions counterfeit, this one takes the cake. A report out of Switzerland note that Italian anti-Mafia prosecutors ordered a seizure in Switzerland of… get this.. $6 TRILLION in fake…
Cell Therapeutics, Inc. (NASDAQ: CTIC) is getting a major boost this morning, but the move is from news out of the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) rather than out of…
Sirius XM Radio (NASDAQ: SIRI) announced this morning that CEO Mel Karmazin has adopted a trading plan for his shares in Sirius XM under the insider selling plan or the 10b5-1 plans. Don’t hit the panic…
Jon OggThese are some of this Friday’s top analyst upgrades, downgrades, and initiations seen in Wall Street research calls. Acorda Therapeutics, Inc. (NASDAQ: ACOR) Cut to Neutral at Citigroup. Arcelor Mittal (NYSE: MT) named as Bear…
DaVita Inc. (NYSE DVA) is turning out to pay off already for Team Buffett over at Berkshire Hathaway Inc. (NYSE: BRK.A). We do not have a real tally of what Buffett’s new portfolio manager paid…
Hecla Mining Company (NYSE: HL) is hoping that high reserves will overshadow mine woes. The troubled silver mining outfit has reported the largest silver reserves and resources in its corporate history. It claims 148…
Gilead Sciences Inc. (NASDAQ: GILD) is being crushed after a disappointing result in its Hepatitis C treatment after reporting that a majority of hepatitis C genotype-1 patients who had a previous null response to…